Cargando…

CD8(+) T-cell immune escape by SARS-CoV-2 variants of concern

Despite the efficacy of antiviral drug repositioning, convalescent plasma (CP), and the currently available vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the worldwide coronavirus disease 2019 (COVID-19) pandemic is still challenging because of the ongoing emergence...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kombe Kombe, Arnaud John, Biteghe, Fleury Augustin Nsole, Ndoutoume, Zélia Nelly, Jin, Tengchuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647062/ https://www.ncbi.nlm.nih.gov/pubmed/36389664 http://dx.doi.org/10.3389/fimmu.2022.962079

Ejemplares similares

Editorial: Host-microbe interaction in SARS-CoV-2 infection: mechanism and intervention
por: Kombe Kombe, Arnaud John, et al.
Publicado: (2023)

Detection of Circulating VZV-Glycoprotein E-Specific Antibodies by Chemiluminescent Immunoassay (CLIA) for Varicella–Zoster Diagnosis
por: Kombe Kombe, Arnaud John, et al.
Publicado: (2022)

Pharmacological Inhibitors of the NLRP3 Inflammasome
por: Zahid, Ayesha, et al.
Publicado: (2019)

Potent Molecular Feature-based Neutralizing Monoclonal Antibodies as Promising Therapeutics Against SARS-CoV-2 Infection
por: Kombe Kombe, Arnaud John, et al.
Publicado: (2021)

Mutations of SARS-CoV-2 spike protein: Implications on immune evasion and vaccine-induced immunity
por: Mengist, Hylemariam Mihiretie, et al.
Publicado: (2021)

Understanding the Secret of SARS-CoV-2 Variants of Concern/Interest and Immune Escape
por: Lou, Fuxing, et al.
Publicado: (2021)

Identification of Novel Therapeutic Candidates Against SARS-CoV-2 Infections: An Application of RNA Sequencing Toward mRNA Based Nanotherapeutics
por: Khalid, Zunera, et al.
Publicado: (2022)

Corrigendum: Identification of novel therapeutic candidates against SARS-CoV-2 infections: An application of RNA sequencing toward mRNA based nanotherapeutics
por: Khalid, Zunera, et al.
Publicado: (2022)

Epidemiology and Burden of Human Papillomavirus and Related Diseases, Molecular Pathogenesis, and Vaccine Evaluation
por: Kombe Kombe, Arnaud John, et al.
Publicado: (2021)

A Detailed Overview of Immune Escape, Antibody Escape, Partial Vaccine Escape of SARS-CoV-2 and Their Emerging Variants With Escape Mutations
por: Chakraborty, Chiranjib, et al.
Publicado: (2022)

Draft Genome Sequences of Three Bacillus Species from South African Marine Sponges
por: van Zyl, Leonardo Joaquim, et al.
Publicado: (2016)

The Effect of Interference on the CD8(+) T Cell Escape Rates in HIV
por: Garcia, Victor, et al.
Publicado: (2015)

Rapid test to assess the escape of SARS-CoV-2 variants of concern
por: Heggestad, Jacob T., et al.
Publicado: (2021)

SARS-CoV-2’s Variants of Concern: A Brief Characterization
por: Scovino, Aline Miranda, et al.
Publicado: (2022)

The Global Epidemic of the SARS-CoV-2 Delta Variant, Key Spike Mutations and Immune Escape
por: Tian, Dandan, et al.
Publicado: (2021)

Implication of SARS-CoV-2 Immune Escape Spike Variants on Secondary and Vaccine Breakthrough Infections
por: Ahmad, Liyana
Publicado: (2021)

SARS-CoV-2 Spike-Specific CD4+ T Cell Response Is Conserved Against Variants of Concern, Including Omicron
por: Mazzoni, Alessio, et al.
Publicado: (2022)

Differential activation of human neutrophils by SARS-CoV-2 variants of concern
por: Lebourgeois, Samuel, et al.
Publicado: (2022)

Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants
por: Weisblum, Yiska, et al.
Publicado: (2020)

Increased immune escape of the new SARS-CoV-2 variant of concern Omicron
por: Hu, Jie, et al.
Publicado: (2022)

Single-Domain Antibodies Efficiently Neutralize SARS-CoV-2 Variants of Concern
por: Favorskaya, Irina A., et al.
Publicado: (2022)

SARS-CoV-2 Variants of Concern and Variants of Interest Receptor Binding Domain Mutations and Virus Infectivity
por: Liu, Haolin, et al.
Publicado: (2022)

A Low Viral Dose in COVID-19 Patient: A Case Report
por: Li, Yajuan, et al.
Publicado: (2020)

In Silico Analysis Predicts a Limited Impact of SARS-CoV-2 Variants on CD8 T Cell Recognition
por: Isaeva, Olga I., et al.
Publicado: (2022)

Novel Monoclonal Antibodies and Recombined Antibodies Against Variant SARS-CoV-2
por: Xie, Jiajia, et al.
Publicado: (2021)

Pan-neutralizing, germline-encoded antibodies against SARS-CoV-2: Addressing the long-term problem of escape variants
por: Lunderberg, Justin Mark, et al.
Publicado: (2022)

Possible contribution of rare alleles of human ACE2 in the emergence of SARS-CoV-2 variants escaping the immune response
por: Devaux, Christian A., et al.
Publicado: (2023)

Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated Vaccine
por: Melo-González, Felipe, et al.
Publicado: (2021)

SARS-CoV-2 bivalent mRNA vaccine with broad protection against variants of concern
por: Ma, Qinhai, et al.
Publicado: (2023)

Rational strategies for enhancing mAb binding to SARS-CoV-2 variants through CDR diversification and antibody-escape prediction
por: Shah, Masaud, et al.
Publicado: (2023)

Identification of Potential SARS-CoV-2 CD8(+) T Cell Escape Mutants
por: Ahmed, Syed Faraz, et al.
Publicado: (2022)

Epitope Classification and RBD Binding Properties of Neutralizing Antibodies Against SARS-CoV-2 Variants of Concern
por: Deshpande, Ashlesha, et al.
Publicado: (2021)

Profiling CD8(+) T cell epitopes of COVID-19 convalescents reveals reduced cellular immune responses to SARS-CoV-2 variants
por: Zhang, Hang, et al.
Publicado: (2021)

Advances in epidermal growth factor receptor specific immunotherapy: lessons to be learned from armed antibodies
por: Biteghe, Fleury Augustin Nsole, et al.
Publicado: (2020)

SARS-CoV-2 Omicron variant (B.1.1.529): A concern with immune escape
por: Sanyaolu, Adekunle, et al.
Publicado: (2022)

Crucial Mutations of Spike Protein on SARS-CoV-2 Evolved to Variant Strains Escaping Neutralization of Convalescent Plasmas and RBD-Specific Monoclonal Antibodies
por: Ding, Chengchao, et al.
Publicado: (2021)

Predicted Epitope Abundance Supports Vaccine-Induced Cytotoxic Protection Against SARS-CoV-2 Variants of Concern
por: Martín-Galiano, Antonio J., et al.
Publicado: (2021)

Third SARS-CoV-2 vaccination and breakthrough infections enhance humoral and cellular immunity against variants of concern
por: Ruhl, Louisa, et al.
Publicado: (2023)

MVA-CoV2-S Vaccine Candidate Neutralizes Distinct Variants of Concern and Protects Against SARS-CoV-2 Infection in Hamsters
por: Boudewijns, Robbert, et al.
Publicado: (2022)

Enhancing quality and integrity in biomedical research in Africa: an international call for greater focus, investment and standardisation in capacity strengthening for frontline staff
por: Kombe, Francis
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_jq3agbv97bp219ec0u5rl1ipbs